Rizatriptan

Product name : Rizatriptan

CAS : 144034-80-0

Molecular formula : C₁₅H₁₉N₅ 

Molecular Weight : 269.34

Product description :
Rizatriptan (Maxalt) is a 5-HT1 agonist triptan drug developed by Merck & Co. for the treatment of migraine headaches. It is available in strengths of 5 and 10 mg as tablets and orally disintegrating tablets (Maxalt-MLT).Maxalt obtained approval by the United States Food and Drug Administration (FDA) on June 29, 1998. It is a second-generation triptan.Rizatriptan is available only by prescription in Australia, the United States, Canada and New Zealand. Similarly, it is classed as a POM (Prescription Only Medicine) in the United Kingdom, Italy (as Rizaliv), Israel (as Rizalt), The Netherlands (as Maxalt), Croatia (as Maxalt) and Spain (as Maxalt).Rizatriptan is used to treat acute migraine attacks. It does not prevent future migraine attacks.